Recordati SpA - Az nom Post raggrupp

OTCPK:RCDTF (Italy)   Az nom Post raggruppamento
$ 51.60 0 (0%) 10:08 PM EST
26.26
P/B:
5.96
Market Cap:
$ 10.94B
Enterprise V:
$ 12.67B
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Avg Vol (2M):
-
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Recordati SpA ( ) from 2010 to May 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Recordati SpA stock (RCDTF) PE ratio as of May 22 2024 is 26.26. More Details

Recordati SpA (RCDTF) PE Ratio (TTM) Chart

To

Recordati SpA (RCDTF) PE Ratio (TTM) Historical Data

Total 1232
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Recordati SpA PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-22 25.6 2024-03-19 25.7
2024-05-21 25.6 2024-03-18 25.7
2024-05-20 25.6 2024-03-15 25.7
2024-05-17 25.6 2024-03-14 25.7
2024-05-16 25.6 2024-03-13 25.7
2024-05-15 25.6 2024-03-12 25.7
2024-05-14 25.6 2024-03-11 25.7
2024-05-13 25.6 2024-03-08 25.7
2024-05-10 25.6 2024-03-07 25.7
2024-05-09 25.6 2024-03-06 25.7
2024-05-08 25.6 2024-03-05 25.7
2024-05-07 25.6 2024-03-04 25.7
2024-05-06 25.6 2024-03-01 25.7
2024-05-03 25.6 2024-02-29 25.7
2024-05-02 25.6 2024-02-28 25.7
2024-05-01 25.6 2024-02-27 25.7
2024-04-30 25.6 2024-02-26 25.7
2024-04-29 25.6 2024-02-23 25.7
2024-04-26 25.6 2024-02-22 25.7
2024-04-25 25.6 2024-02-21 25.7
2024-04-24 25.6 2024-02-20 25.7
2024-04-23 25.6 2024-02-16 25.7
2024-04-22 25.6 2024-02-15 25.7
2024-04-19 25.6 2024-02-14 25.7
2024-04-18 25.6 2024-02-13 25.7
2024-04-17 25.6 2024-02-12 25.7
2024-04-16 25.6 2024-02-09 25.7
2024-04-15 25.6 2024-02-08 25.7
2024-04-12 25.6 2024-02-07 25.7
2024-04-11 25.6 2024-02-06 25.7
2024-04-10 25.6 2024-02-05 25.7
2024-04-09 25.6 2024-02-02 25.7
2024-04-08 25.6 2024-02-01 25.7
2024-04-05 25.6 2024-01-31 25.7
2024-04-04 25.6 2024-01-30 25.7
2024-04-03 25.6 2024-01-29 25.7
2024-04-02 25.6 2024-01-26 25.7
2024-04-01 25.6 2024-01-25 25.7
2024-03-28 25.6 2024-01-24 25.9
2024-03-27 25.7 2024-01-23 22.9
2024-03-26 25.7 2024-01-22 22.9
2024-03-25 25.7 2024-01-19 22.9
2024-03-22 25.7 2024-01-18 22.9
2024-03-21 25.7 2024-01-17 22.9
2024-03-20 25.7 2024-01-16 22.9

Recordati SpA (RCDTF) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Recordati SpA
NAICS : 325412 SIC : 2834
ISIN : IT0003828271

Share Class Description:

RCDTF: Az nom Post raggruppamento
Description
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.